Maxillofacial Plastic and Reconstructive Surgery

  • Volume 41
  • /
  • Pages.42.1-42.15
  • /
  • 2019
  • /
  • 2288-8101(pISSN)
  • /
  • 2288-8586(eISSN)
Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지
DOI QR코드

DOI QR Code

Application of botulinum toxin in maxillofacial field: Part II. Wrinkle, intraoral ulcer, and cranio-maxillofacial pain

  • Kwon, Kyung-Hwan (Department of Oral and Maxillofacial Surgery, College of Dentistry, Wonkwang University) ;
  • Shin, Kyung Su (Department of Oral and Maxillofacial Surgery, College of Dentistry, Wonkwang University) ;
  • Yeon, Sung Hee (Department of Oral and Maxillofacial Surgery, College of Dentistry, Wonkwang University) ;
  • Kwon, Dae Gun (Department of Oral and Maxillofacial Surgery, College of Dentistry, Wonkwang University)
  • Received : 2019.06.14
  • Accepted : 2019.08.26
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Botulinum toxin (BTX) is used in various ways such as temporarily resolving muscular problems in musculoskeletal temporomandibular disorders, inducing a decrease in bruxism through a change in muscular patterns in a patient's bruxism, and solving problems in patients with tension headache. And also, BTX is widely used in cosmetic applications for the treatment of facial wrinkles after local injection, but conditions such as temporomandibular joint disorders, headache, and neuropathic facial pain could be treated with this drug. In this report, we will discuss the clinical use of BTX for facial wrinkle, intraoral ulcer, and cranio-maxillofacial pain with previous studies and share our case.

Keywords

References

  1. Carruther A, Carruthers J (1998) Clinical indications and injections technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 24:1189-1194 https://doi.org/10.1111/j.1524-4725.1998.tb04097.x
  2. Hankins CL, Strimling R, Roger GS (1998) Botulinum A toxin for glabellar wrinkles. Dose and response. Dermatol Surg 24:1181-1183 https://doi.org/10.1111/j.1524-4725.1998.tb04095.x
  3. Bulstrode NW, Grobbelaar AO (2002) Long-term prospective follow-up of botulinum toxin treatment for facial rhytides. Aesthetic Plast Surg 26:356-359 https://doi.org/10.1007/s00266-002-2047-1
  4. Sarrabayrouse MA (2002) Indication and limitations for use of botulinum toxin for the treatment of facial wrinkles. Aesthetic Plast Surg 26:233-238 https://doi.org/10.1007/s00266-002-2030-x
  5. Jones OM, Brading AF, Mortensen NJ (2004) Mechanism of action of botulinum toxin on the internal anal sphincter. Br J Surg. 91:224-228 https://doi.org/10.1002/bjs.4394
  6. Yoon HC (2002) How to use botulinum toxin for treatment. Future Publishing, Busan
  7. Wieder JM, Moy RL (1998) Understanding botulinum toxin: surgical anatomy of the frown, foreahead, and periocular region. Dermatol Surg 24:1172-1174 https://doi.org/10.1111/j.1524-4725.1998.tb04093.x
  8. Edward Ellis III, Zide MF (1995) Surgical approaches to the facial skeleton. Wolters Kluwer, Philadelphia
  9. Matarasso SL (1998) Complications of botulinum A exotoxin for hyperfunctional lines. Dermatol Surg. 24:1249-1254 https://doi.org/10.1111/j.1524-4725.1998.tb04106.x
  10. Benedetto AV (1999) The cosmetic uses of botulinum toxin type A. Int J Dermatol. 38:641-655 https://doi.org/10.1046/j.1365-4362.1999.00722.x
  11. Carruthers J, Carruthers A. (1991) Botulinum toxin use on glabellar wrinkles. Presented at the annual meeting of the American Society for dermatologic surgery Orlando Florida. 13-17 March. 1991.
  12. Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17-21 https://doi.org/10.1111/j.1524-4725.1992.tb03295.x
  13. McCurdy JA Jr (1990) Cosmetic surgery of Asian face. Thieme Medical Publishers, New York
  14. Price J, O'Day J (1993) A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin. J Clin Neuroophthalmol 13:67-71.
  15. Le Louarn C (2001) Botulinum toxin A and facial lines: the variable concentration. Aesthetic Plastic Surgery 25:73-84 https://doi.org/10.1007/s002660010100
  16. Cheng CM, Chen JS, Patel RP (2006) Unlabeled uses of botulinum toxins: a review, part 1. Am J Health Syst Pharm 63:145-152 https://doi.org/10.2146/ajhp050137
  17. Cheng CM, Chen JS, Patel RP (2006) Unlabeled uses of botulinum toxins: a review, part 2. Am J Health Syst Pharm 63:225-232 https://doi.org/10.2146/sp/06001
  18. Eisenberg E (2003) Diagnosis and treatment of recurrent aphthous stomatitis. Oral Maxillofac Surg Clin North Am 15:111-122 https://doi.org/10.1016/S1042-3699(02)00070-5
  19. Yang TY, Jang TY (2009) The value of local botulinum toxin A injection in the treatment of the pain of aphthous ulcer. Eur Arch Otorhinolaryngol 266:445-448 https://doi.org/10.1007/s00405-008-0756-z
  20. Leviton A (1978) Epidemiology of headaches. In: Schoenberg BS (ed) Advances in Neurology. Raven Press, New York
  21. Borodic GE, Acquadro M, Johnson EA (2001) Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drugs 10:1531-1544 https://doi.org/10.1517/13543784.10.8.1531
  22. Tan EK, Jankovic J (2000) Treating severe bruxism with botulinum toxin. J Am Dent Assoc 131:211-216 https://doi.org/10.14219/jada.archive.2000.0149
  23. Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y (2005) Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 25:604-611 https://doi.org/10.1007/s00296-004-0485-6
  24. Wheeler AH, Goolkasian P, Gretz SS (2001) Botulinum toxin A for the treatment of chronic neck pain. Pain 94:255-260 https://doi.org/10.1016/S0304-3959(01)00358-X
  25. Cheshire WP, Abashian SW, Mann JD (1994) Botulinum toxin in the treatment of myofascial pain syndrome. Pain 59:65-69 https://doi.org/10.1016/0304-3959(94)90048-5
  26. Binder WJ, Blitzer A (2003) Treatment of migraine headache with botulinum toxin type A. Facial Plast Surg Clin North Am 11:465-475 https://doi.org/10.1016/S1064-7406(03)00076-2
  27. International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the International Headache Society. Cephalalgia 7:1-96 https://doi.org/10.1046/j.1468-2982.1987.0701001.x
  28. Okeson JP (2008) The classification of orofacial pains. Oral Maxillofac Surg Clin North Am 20:133-144 https://doi.org/10.1016/j.coms.2007.12.009
  29. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM (2000) Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123:669-676 https://doi.org/10.1067/mhn.2000.110960
  30. Freund B, Schwartz M, Symington JM (1999) The use of botulinum toxin for the treatment of temporomandibular disorders: preliminary findings. J Oral Maxillofac Surg 57:916-920 https://doi.org/10.1016/S0278-2391(99)90007-1
  31. Archana MS (2016) Toxin yet not toxic: botulinum toxin in dentistry. Saudi Dent J 28:63-69 https://doi.org/10.1016/j.sdentj.2015.08.002
  32. Lu DW, Lippitz J (2009) Complications of botulinum neurotoxin. Dis Mon 55:198-211 https://doi.org/10.1016/j.disamonth.2009.01.001
  33. Niamtu J 3rd (2003) Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg 61:317-324 https://doi.org/10.1053/joms.2003.50069